Mercuric Chloride
Mercurial Products
Sold as Vermex · Renapar · Terebinthina Combination…
- Drug class
- Mercurial Products
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 3
- FDA reports (12 mo)
- 79
Overview
Plain-language summary, compiled from the cited regulatory records
Mercuric Chloride is a mercurial product [1]. It is approved to temporarily relieve symptoms associated with urinary urgency, difficulty, and frequency [1]. These claims are based on traditional homeopathic practice and have not been evaluated by regulatory bodies [1].
This active ingredient is available under various brand names, including Renapar, Vermex, and Terebinthina Combination 9248 [1]. In the past 12 months, there have been 79 adverse event reports associated with products containing Mercuric Chloride [2]. The most frequently reported adverse events include dyspnoea, eye pain, malaise, product use in an unapproved indication, and decreased weight [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 3 | January 8, 2026 |
USUnited States· FDA
3 products
Uses
** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
How to take
Sources & citations
- [1]FDA DailyMed · 0515331b-c3d2-44… · revised December 1, 2023 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.